MDT Trading Analysis - 10/16/2026 03:38 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge headlines and context for Medtronic (MDT) that may frame the current data:

• Medtronic reported mixed Q1 fiscal 2027 results in late August 2026, with cardiovascular momentum offset by soft diabetes sales; shares stabilized after the print.
• In September 2026, MDT announced FDA clearance for a next-gen pulse generator, a potential catalyst for the cardiac rhythm business into year-end.
• Management highlighted supply-chain normalization on the September investor call, reducing prior execution risk.
• Ex-dividend date passed on 2026-09-25 ($2.88 annual rate), which often creates near-term price drift lower before recovery.
• Broad medtech sentiment improved in October 2026 on lower-rate expectations, supporting a rotation into large-cap devices like MDT.

Context: The embedded price data shows a sharp October rebound from the $85 area to $95.75, consistent with post-ex-dividend recovery and sector tailwinds rather than a single discrete news shock.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

• Trailing P/E: 23.40; Trailing EPS: $4.08; Market Cap: $121.08B; Shares Outstanding: 1.28B.
• Dividend Yield: 3.02% ($2.88 rate); Ex-Dividend Date: 2026-09-25.
• Beta: 0.49 (low market sensitivity); 52-Week Range: $73.31 to $106.33.
• Institutional Ownership: 60.11%; Average Volume: 33.12M; Historical Volatility: 24.02%.
• PEG Ratio, Forward P/E, Profit Margins, ROE, Debt/Equity, and Free Cash Flow are null in the data — cannot be assessed.
• Analyst consensus and target mean price are null — no external target context available.

Alignment: Fundamentals show a low-beta, dividend-paying large-cap with moderate valuation (P/E 23.40) and a 3.02% yield. The technical rebound to $95.75 sits mid-range vs the 52-week high of $106.33, suggesting fundamental stability supports the recent price recovery without obvious overvaluation from the embedded metrics.

Current Market Position

Current price per indicators: $95.76 (2026-10-15 close $95.76 from daily, minute bars end 2026-10-16 at $94.66). Recent daily action shows a push from $85.97 (2026-10-02) to $95.76 (2026-10-15), a gain of ~11.4% over two weeks.

Minute bars (2026-10-15 09:30 to 2026-10-16 15:10) show opening at $95.00, high $95.76, then drift to $94.66 by final bar — mild intraday softening after the spike, with last 5 bars ranging $94.47–$94.66 on moderate volume (~110K/bar).

Technical Analysis

SMAs are aligned bullish: price ($95.76) > SMA 5 ($92.44) > SMA 50 ($90.69) > SMA 20 ($89.35) — note SMA 20 below SMA 50 indicates prior base, now with price above both. RSI 69.08 shows strong momentum near overbought (70 threshold). MACD histogram positive (0.13) confirms bullish crossover. Price is above Bollinger upper ($94.83), indicating extension. 30-day range: high $95.94, low $85.22; current $95.76 is ~99.8% of range high.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only):

Call Volume: $953,055 (63.2%) Put Volume: $555,266 (36.8%) Total: $1,508,321

Sentiment: Bullish. Call dollar volume leads by ~1.7x; 29 call trades vs 15 put trades shows directional conviction to upside. This aligns with technical breakout above $94.83 BB upper and SMA stack. No divergence seen — sentiment confirms price strength.

Key Price Levels (Observational Only)